XLOXilio Therapeutics Inc

$8.32
$0.07
(0.85%)
Pre-Market
Updated: 06:55 AM EDT·Prev Close $8.25
Mkt Cap$54.84M
Vol8.00

About

Xilio Therapeutics, Inc. operates as a biotechnology company. It focuses on the discovery and development of tumor-activated immuno-oncology therapies for the treatment of cancer. The firm uses its Geographically Precise Solutions (GPS) platform to develop tumor-activated molecules, including cytokines, antibodies and other biologics. The company was founded by John C. Williams and Ulrich Rodeck in June 2015 and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
76

Frequently Asked Questions

What is Market Cap of Xilio Therapeutics Inc?
What is the 52-week high for Xilio Therapeutics Inc?
What is the 52-week low for Xilio Therapeutics Inc?
What is Xilio Therapeutics Inc stock price today?
What was Xilio Therapeutics Inc stock price yesterday?
What is the PE ratio of Xilio Therapeutics Inc?
What is the Price-to-Book ratio of Xilio Therapeutics Inc?
What is the 50-day moving average of Xilio Therapeutics Inc?
How many employees does Xilio Therapeutics Inc have?

Advertisement|Remove ads.